Evomela is given by a doctor or nurse and billed by the clinic, not a pharmacy. Your care team and your insurance decide which product you get, so ask them what you’d pay.

How do you pay?

How to pay the least

Given by your care team

Billed by the clinic

Evomela is given by a doctor or nurse, not picked up at a pharmacy.

  1. Ask your care team or your plan what you’d pay before your visit.

Compare every option

Question
Brand nameEvomela
Authorized genericmelphalan
Regular genericmelphalan
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldNone found
Same as Evomela?
The original
–
–

Brand nameThe maker’s card

Acrotech Access Support co-pay assistance

Savings card from Acrotech Biopharma

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $25 an infusion

The card takes up to $10,000 a year off your co-pay.

Sign up on acrotechpatientaccess.com 

In the maker’s words

“Subsequent Dates of Service: Patient will be responsible for the first $25 of the co-insurance/cost share for the Acrotech product. STAR will cover the remaining cost share for the Acrotech product at 100%.”

From the maker’s offer on acrotechpatientaccess.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Authorized genericNot sold

There isn’t one. An authorized generic is Evomela itself, from the same company, sold without the brand name, and usually for less. For now Evomela is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

Evomela is an alkylating drug indicated for use as a high-dose conditioning treatment prior to hematopoietic progenitor (stem) cell transplantation in patients with multiple myeloma.

Source: the FDA label for Evomela (Acrotech Biopharma Inc), September 15, 2026. Full label on DailyMed 

Good to know